International Journal of Myeloma (IJM) is an international, peer-reviewed, interdisciplinary publication encompassing clinical, physiological, pathological, genetic/cytogenetic and medical research on plasma cell dyscrasias, including multiple myeloma, plasma cell leukemia, plasmacytomas, amyloidosis, POEMS syndrome, and monoclonal gammopathy of undetermined significance. The Journal welcomes original contributions dealing with all aspects of plasma cell dyscrasias, including clinical and fundamental studies. The journal welcomes articles described by either English or Japanese language, while prefers English articles for more world-wide activity.